| CL3130 |
|
677338-12-4 |
N-(7,8-二甲氧基-2,3-二氫咪唑并[1,2-c]喹唑啉-5-基)煙酰胺
PIK-90
-
98+%
|
需詢價 |
C18H17N5O3 |
|
|
|
| CL1320A |
|
934389-88-5 |
LY294002 HCl
LY294002 hydrochloride
-
98+%
|
需詢價 |
C19H17NO3·HCl |
|
|
|
| CL2885 |
|
677297-51-7 |
3,3'-(2,4-二氨基-6,7-蝶啶二基)二苯酚
TG100-115
-
98+%
|
需詢價 |
C18H14N6O2 |
|
|
|
| CL1332A |
|
1584128-91-5 |
阿培利司鹽酸鹽
Alpelisib hydrochloride
-
98+%
|
需詢價 |
C19H23ClF3N5O2S |
|
|
|
| CL2744 |
|
1197160-78-3 |
吉達利塞
Gedatolisib | PKI-587 | PF-05212384
-
98+%
|
需詢價 |
C32H41N9O4 |
|
|
|
| CL2601 |
|
915019-65-7 |
2-甲基-2-(4-(3-甲基-2-氧代-8-(喹啉-3-基)-2,3-二氫-1H-咪唑并[4,5-c]喹啉-1-基)苯基)丙腈
NVP-BEZ235 (Synonyms: Dactolisib; BEZ235;達克利司)
-
98+%
|
需詢價 |
C30H23N5O |
|
|
|
| CL1233 |
|
2060571-02-8 |
Inavolisib | GDC-0077
Inavolisib | GDC-0077 | RG6114 | RO-7113755
3-5days
98+%
|
￥866.00 |
C18H19F2N5O4 |
|
|
|
| CL1332 |
|
1217486-61-7 |
阿培利司 | 阿培利斯
Alpelisib | BYL-719
-
98+%
|
需詢價 |
C19H22F3N5O2S |
|
|
|
| CL1337 |
|
1086062-66-9 |
GSK2126458
Omipalisib | GSK2126458 | GSK458
3-5days
98+%
|
￥336.00 |
C25H17F2N5O3S |
|
|
|
| CL2026 |
|
957054-30-7 |
匹替利司 | 2-(1H-吲唑-4-基)-6-[[4-(甲基磺?；?-1-哌嗪基]甲基]-4-(4-嗎啉基)噻吩并[3,2-d]嘧啶; 匹替利司
Pictilisib | GDC-0941 | RG7321
-
98+%
|
需詢價 |
C23H27N7O3S2 |
|
|
|
